Symrise AG (SWX:SY1)
Switzerland
· Delayed Price · Currency is CHF | Market Cap | 9.38B |
| Revenue (ttm) | 4.59B |
| Net Income (ttm) | 232.13M |
| Shares Out | n/a |
| EPS (ttm) | 1.66 |
| PE Ratio | 40.40 |
| Forward PE | 18.85 |
| Dividend | 1.12 (1.64%) |
| Ex-Dividend Date | May 21, 2025 |
| Volume | n/a |
| Average Volume | 2 |
| Open | 68.64 |
| Previous Close | 68.64 |
| Day's Range | 68.64 - 68.64 |
| 52-Week Range | 65.84 - 69.80 |
| Beta | n/a |
| RSI | 75.02 |
| Earnings Date | Apr 29, 2026 |
About Symrise AG
Symrise AG operates as a supplier of fragrances, flavorings, cosmetic base materials and active ingredients, and functional ingredients and solutions in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. It operates in two segments, Taste, Nutrition & Health; and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and product solutions used in the production of food and beverages; savory flavors; sweets, chocolate, chewing gum, baked goods, cereals, ice cream, milk, yogurt and mi... [Read more]
Financial Performance
In 2025, Symrise AG's revenue was 4.93 billion, a decrease of -1.39% compared to the previous year's 5.00 billion. Earnings were 249.33 million, a decrease of -47.86%.
Financial numbers in EURNews
EQS-PVR: Symrise AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Symrise AG Symrise AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 20.04.2...
Symrise AG Earnings Call Transcript: Q4 2025
2025 saw resilient organic growth, record profitability, and strong cash flow despite FX and market headwinds. Strategic transformation, portfolio optimization, and efficiency gains drove margin expansion, while 2026 guidance remains prudent amid macro uncertainty, with growth expected to accelerate in H2.
Symrise AG Earnings Call Transcript: Q3 2025
Q3 2025 saw 1.4% organic sales growth, with strong performance in EMEA and food & beverage, but softness in North America and Latin America. Full-year growth guidance was lowered to 2.3%-3.3% amid macro headwinds, while cost savings and margin targets remain on track.
Symrise and Aplantex Confirm an Agreement to Establish a Partnership
MONTREAL--(BUSINESS WIRE)--Symrise AG ("Symrise") and Aplantex Bio ("Aplantex") agree on a partnership covering new technologies for accessing plant-based molecules as raw material once the molecules ...
Symrise AG Earnings Call Transcript: Q2 2025
Solid H1 2025 results with 3.1% organic sales growth, 12% net income increase, and improved margins driven by efficiency gains and cost savings. Guidance for full-year organic growth was moderated to 2%-5%, but margin and cash flow targets were raised, reflecting confidence in ongoing transformation.
Symrise AG Earnings Call Transcript: Q1 2025
Double-digit organic growth in beverages and strong performance in APAC and EAME drove industry-leading results, while Scent & Care and Aroma Molecules posted high single-digit growth. Guidance for 2025 and 2028 was reaffirmed, with ongoing innovation, efficiency initiatives, and strategic portfolio management supporting future growth.
Hofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUP
HBC will accelerate its manufacturing scale and market reach with the construction of a second enzymatic hydrolysis plant in Berkåk, Norway. Symrise will support the financing of the project through a...
Symrise AG Earnings Call Transcript: Q4 2024
Organic growth reached 8.7% in 2024, with EBITDA surpassing €1 billion and net income up 40% year-over-year. Both main segments and all regions contributed, and 2025 guidance targets 5%-7% organic growth and a 21% EBITDA margin.
Symrise AG Earnings Call Transcript: Q3 2024
Group sales rose 11.1% organically in the first nine months, driven by strong volume growth in both segments, but hyperinflation effects—mainly from Argentina—will create a Q4 headwind, leading to a full-year organic sales growth guidance of around 7% excluding hyperinflation.
Symrise AG Earnings Call Transcript: Q2 2024
Strong H1 2024 results with 11.5% organic sales growth, improved margins, and robust cash flow. Guidance for 2024 is reaffirmed, with disciplined CapEx and continued efficiency gains supporting long-term targets.